Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024 10:25 ET
|
FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option
December 21, 2023 16:00 ET
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option Closes acquisition of...
Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innovation Fund and ARTIS Ventures
December 19, 2023 09:00 ET
|
Unnatural Products
Santa Cruz, CA, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to usher in the next generation of molecularly targeted therapeutics,...
Biopharmaceutical CMO Market Size, Share & Growth Analysis, [2028] | With CAGR of 12.6%
December 19, 2023 05:46 ET
|
Fortune Business Insights
Pune, India, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The Biopharmaceutical CMO Market size was expected to be worth USD 11.56 billion in 2021 and projected to reach USD 26.49 billion by 2028, recording a...
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
December 14, 2023 07:05 ET
|
Clearside Biomedical, Inc.
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
Biodexa Enters Into Agreements to Acquire Exclusive Worldwide License to Tolimidone, a Phase II Ready Asset for Type 1 Diabetes
November 27, 2023 09:00 ET
|
Biodexa Pharmaceuticals PLC
Cardiff , Nov. 27, 2023 (GLOBE NEWSWIRE) -- 27 November 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Agreements to Acquire Exclusive Worldwide License to...
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 14, 2023 07:30 ET
|
DMK Pharmaceuticals Corporation
Rebranded company to DMK Pharmaceuticals and appointed inaugural, passionate and committed leadership team to execute on new strategy to reduce opioid related deaths through enhanced sales of ZIMHI®...
Compass Therapeutics to Participate in Upcoming Investor Events
November 07, 2023 08:00 ET
|
Compass Therapeutics
BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Global Cold Storage Construction Market to Reach Value of USD 35.48 Billion by 2032 | Emergen Research
November 06, 2023 09:19 ET
|
Emergen Research
Vancouver, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The global cold storage construction market is projected to reach a market size of USD 35.48 Billion by 2032, and revenue growth is expected to be...
Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
November 06, 2023 07:30 ET
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Nov. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today announced that the Israel Innovation Authority (IIA) has approved a non-dilutive grant...